Prolia® Essentials

PROLIA® IS AN EFFECTIVE AND WELL-TOLERATED TREATMENT THAT IMPROVES BONE STRENGTH AND REDUCES FRACTURE RISK1

Prolia® is indicated for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal women, Prolia® significantly reduces the risk of vertebral, non-vertebral and hip fractures.2
Prolia® is a targeted therapy with a unique mode of action that increases both cortical and trabecular bone strength.2–4

References:
  1. Bone HG, et al. Lancet Endocrinol Diabetes. 2017;5:513–23.
  2. Prolia® (denosumab) Summary of Product Characteristics. Amgen.
  3. Baron R, et al. Bone. 2011;48:677–92.
  4. McClung MR, et al. J Clin Densitom. 2013;16:250–6.

SMPC

The information contained in this site is for healthcare professionals only

I am a patient
I am a member of the public